Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction

This publication has 23 references indexed in Scilit:

• Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
  Journal of the American College of Cardiology, 1997
• The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts
  Cardiovascular Research, 1996
• Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of “preconditioning”
  Journal of the American College of Cardiology, 1995
• Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.
  Circulation, 1993
• Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy
  Journal of the American College of Cardiology, 1993
• Preconditioning the human myocardium
  The Lancet, 1993
• Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
  Journal of the American College of Cardiology, 1993
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
  Circulation, 1986
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
  Journal of the American College of Cardiology, 1985